Literature DB >> 11389308

Vesicoureteral reflux.

R M Decter1.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11389308     DOI： 10.1542/pir.22-6-205

Source DB:  PubMed          Journal:  Pediatr Rev        ISSN： 0191-9601


× No keyword cloud information.
  4 in total

1.  Clinical and laboratory characteristics of non-E. coli urinary tract infections.

Authors:  S Friedman; S Reif; A Assia; Ram Mishaal; I Levy
Journal:  Arch Dis Child       Date:  2006-05-22       Impact factor: 3.791

2.  Urinary tract infections, VUR, and autosomal dominant polycystic kidney disease.

Authors:  Oren Koslowe; Rachel Frank; Bernard Gauthier; Marcela Vergara; Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2003-06-17       Impact factor: 3.714

3.  An Open-Label, Noncomparative, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx Gel as a Bulking Agent for the Treatment of Fecal Incontinence.

Authors:  Giuseppe Dodi; Johannes Jongen; Fernando de la Portilla; Manoj Raval; Donato F Altomare; Paul-Antoine Lehur
Journal:  Gastroenterol Res Pract       Date:  2010-12-27       Impact factor: 2.260

4.  Patients with a history of infection and voiding dysfunction are at risk for recurrence after successful endoscopic treatment of vesico ureteral reflux and deserve long-term follow up.

Authors:  R Coletta; C Olivieri; V Briganti; M L Perrotta; L Oriolo; F Fabbri; A Calisti
Journal:  Urol Ann       Date:  2012-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.